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The carboxyl-terminal membrane-spanning segment 8
of the glutamate transporter GltT of Bacillus stearother-
mophilus was studied by cysteine-scanning mutagene-
sis. 21 single cysteine mutants were constructed in a
stretch ranging from Gly-374 to Gln-404. Two mutants
were not expressed, four were inactive, and two showed
severely reduced glutamate transport activity. Cysteine
mutations at the other positions were well tolerated.
Only the two most amino- and carboxyl-terminal mu-
tants (G374C, I375C, S399C, and Q404C) could be labeled
with the large thiol reagent fluorescein maleimide, indi-
cating unrestricted access and a location in a loop struc-
ture outside the membrane. The labeling pattern of
these mutants using membrane- permeable and -imper-
meable thiol reagents showed that the N and C termini
of the mutated stretch are located extra- and intracellu-
larly, respectively. Thus, the location of the membrane-
spanning segment was confined to a stretch of 23 resi-
dues between Gly-374 and Ser-399. Cysteine residues in
three mutants in the central part of the segment (M381C,
V388C, and N391C) could be labeled with the small and
flexible reagent 2-aminoethyl methanethiosulfonate hy-
drobromide only, suggesting accessibility via a narrow
aqueous pore. When the region was modeled as an a-he-
lix, all positions at which cysteine mutations lead to
inactive or severely impaired transporters cluster on
one face of this helix. The inactive mutants showed nei-
ther proton motive force-driven uptake activity nor ex-
change activity nor glutamate binding. The results indi-
cate that transmembrane segment 8 forms an
amphipathic a-helix. The hydrophilic face of the helix
lines an aqueous pore and contains many residues that
are important for activity.
Glutamate transporters in the mammalian central nervous
system remove the neurotransmitter glutamate from the syn-
aptic cleft into surrounding neurons and glial cells. Removal of
glutamate prevents neurotoxicity of high concentrations of glu-
tamate and helps to end the excitatory signal at some synapses
(1–4). The proteins are secondary transporters that couple
glutamate transport against the concentration gradient to the
transport of protons, sodium ions, and potassium ions across
the membrane. The glutamate transporters belong to a large
family of transport proteins in which are also found bacterial
glutamate transporters including GltT of Bacillus stearother-
mophilus (5). Computational analyses of the amino acid se-
quences and hydropathy profiles of the glutamate transporters
showed that the proteins form a unique structural class of
membrane proteins, which is structurally not related to any
other family of secondary transporters (5, 6). Subsequent ex-
perimental studies confirmed that the proteins contain unique
structural features, like water-filled pores and pore loops,
which are not found in “regular” secondary transporters (7–11).
The amino-terminal half of the transporters contains six
membrane-spanning a-helices, with the amino terminus of the
proteins located in the cytoplasm. The membrane topology of
the carboxyl-terminal half of the transporters is still somewhat
controversial. However, in the most generally accepted model
the six amino-terminal a-helices are followed by a reentrant
loop entering the membrane from the cytoplasmic side, a sev-
enth membrane-spanning helix, a reentrant loop entering the
membrane from the extracellular side and, finally, an eighth
membrane-spanning segment, leaving the carboxyl terminus
in the cytoplasm (Fig. 1). The eukaryotic and prokaryotic glu-
tamate transporters differ predominantly in the length of their
hydrophilic regions. Three hydrophilic stretches are consider-
ably longer in the eukaryotic proteins: the amino-terminal and
carboxyl-terminal extensions and the region between the third
and fourth membrane-spanning segment, which is glycosylated
in the eukaryotic members. Evidence is accumulating that the
carboxyl-terminal half of the transporters, which is particu-
larly well conserved, constitutes a major part of the transloca-
tion pathway and contains the binding sites for the substrate
and cotransported ions (7, 12–18). The bacterial and eukaryotic
glutamate transporters have different coupling ion specificity.
The bacterial proteins catalyze the electrogenic symport of
glutamate with two protons or a proton and a sodium ion. The
eukaryotic glutamate transporters catalyze the electrogenic
symport of glutamate with three sodium ions and one proton,
whereas one potassium ion is antiported.
The location of the most carboxyl-terminally located mem-
brane-spanning segment (segment 8), which enters the mem-
brane from the extracellular side and runs to the cytoplasmic
side, is particularly ill defined. Previous cysteine-scanning mu-
tagenesis studies with two glutamate transporters (human
EAAT1 and rat EAAT2) have restricted the membrane-span-
ning segment to a stretch of about 50 amino acids (10, 11).
Hydropathy profile analysis is not very helpful in defining the
position of segment 8 more accurately because the region is
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relatively hydrophilic and does not contain a stretch of ;20
hydrophobic residues, which is characteristic for membrane-
spanning a-helices. The secondary structure of membrane-
spanning segment 8 has been a matter of debate, and it has
been modeled both as an a-helix and a b-strand (10, 11, 16, 19).
A b-strand structure was suggested because of the hydrophilic
nature of the region (11, 19), whereas an a-helical structure
was suggested on the basis of computational analysis of perio-
dicity in the amino acid sequences of the glutamate transport-
ers (5, 16). No firm experimental evidence for either structure
has been presented.
Here, cysteine-scanning mutagenesis is applied to the region
containing membrane-spanning segment 8 in the glutamate
transporter GltT of B. stearothermophilus. The position of the
membrane-spanning segment is confined to a stretch of 23
amino acids, which is likely to adopt an a-helical conformation.
The segment lines an aqueous channel and contains many
residues that are of crucial importance for glutamate binding
and transport.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Growth Conditions
Escherichia coli strain ECOMUT2, which lacks the glutamate trans-
porter GltP (20), was used to express GltT mutants and was grown in
Luria Broth medium at 37 °C. Chloramphenicol and ampicillin were
used at final concentrations of 30 mg/ml and 100 mg/ml, respectively.
Expression of GltT mutants from pBAD24-derived plasmids (21) was
induced by adding 0.15% L-arabinose at an A600 of 0.5, and cells were
harvested 1.5 h after induction.
Recombinant DNA Techniques
General molecular biological techniques are described by Sambrook
et al. (22). Enzymes for recombinant DNA work were obtained from
Roche Molecular Biochemicals (Germany). The polymerase chain reac-
tion overlap extension method (23) was used to introduce mutations in
the gltT gene on a pBAD24-derived expression plasmid, which encodes
GltT with an amino-terminal His tag consisting of six adjacent histi-
dines (9). Oligonucleotides were obtained from Life Technologies, Inc.
All polymerase chain reaction-amplified DNA fragments were se-
quenced by BMTC (Groningen, The Netherlands).
Preparation of Membrane Vesicles
Membrane vesicles with a rightside-out orientation were prepared
from E. coli ECOMUT2 cells expressing GltT mutants by the osmotic
lysis procedure, as described by Kaback (24). Randomly oriented mem-
brane vesicles and membrane vesicles with an inside-out orientation
were prepared with sonication and passage through a French pressure
cell, respectively, as described previously (9). Membrane vesicles were
stored in liquid nitrogen at a protein concentration of 10 mg/ml in 50
mM potassium phosphate, pH 7. The protein concentration was deter-
mined with the DC protein assay from Bio-Rad. Expression levels of
His-tagged proteins were determined by running membrane vesicles
(20 mg of protein) on SDS-polyacrylamide gels followed by transfer to
poly(vinylidene difluoride) membranes (Roche Molecular Biochemicals)
and detection with monoclonal antibodies directed against a 6 His tag
(Dianova, Hamburg, Germany). Antibodies were visualized by using
the Western light chemiluminescence detection kit (Tropix, Bedford,
MA).
Purification and Reconstitution
GltT mutant proteins were purified and reconstituted into proteoli-
posomes as described before (25) with the following minor modifica-
tions. The detergent n-dodecyl-b-D-maltoside (Anatrace, Ohio) was used
instead of Triton X-100 to solubilize cytoplasmic membranes (0.4 mg/4
mg of membrane protein) and during purification of GltT (0.03%).
Triton X-100 was still used to destabilize preformed liposomes (25). The
lipid to protein ratio during reconstitution was 330 (w/w). The protein
concentration was determined with the DC protein assay from Bio-Rad.
Proteoliposomes were stored in liquid nitrogen an appropriate buffer
(see below).
Labeling of Membrane Vesicles and Proteoliposomes
Unless stated otherwise, membrane vesicles with a rightside-out
orientation (10 mg of protein/ml) were labeled for 10 min at room
temperature with 0.25 mM N-ethylmaleimide (NEM)1 or with the meth-
anethiosulfonate reagents (2-(trimethylammonium)ethyl) methaneth-
iosulfonate bromide (MTSET, 1 mM) and 2-aminoethyl methanethiosul-
fonate hydrobromide (MTSEA, 2.5 mM) (Anatrace, Ohio). Immediately
after labeling, glutamate uptake experiments were performed with
these membrane vesicles using artificial gradients.
Membrane vesicles with a random orientation (500 ml, 2 mg of
protein/ml in 50 mM potassium phosphate, pH 7) were labeled with 0.25
mM fluorescein maleimide (Molecular Probes, Eugene, Oregon) for 10
min at room temperature. The reaction was stopped by adding a 10-fold
excess of dithiothreitol, followed by small scale purification of His-
tagged GltT mutants using Ni21-nitrilotriacetic acid agarose (9). Puri-
fied proteins were run on SDS-polyacrylamide gels. Fluorescence of
proteins labeled with fluorescein maleimide was visualized by UV ex-
citation using a Gel-Doc system (Bio-Rad).
Proteoliposomes (30 mg of protein) were labeled with 0.25 mM NEM
or 0.25 mM 4-acetamido-49-maleimidylstilbene-2,29-disulfonic acid
(AMdiS) at room temperature for 10 min in 50 mM potassium phos-
phate, pH 7. The reaction was stopped with a 10-fold excess of dithio-
threitol. The labeled proteoliposomes were washed once with 50 mM
potassium phosphate, pH 7, and solubilized in 300 ml of the same buffer
containing 2% Triton X-100. 0.25 mM fluorescein maleimide was added,
and the mixture was incubated for 10 min at room temperature. The
reaction was stopped with a 10-fold excess of dithiothreitol. Proteins
were precipitated with trichloroacetic acid and run on SDS-polyacryl-
amide gels. Fluorescence of proteins labeled with fluorescein maleimide
was visualized using a Lumi-imager (Roche).
Glutamate Transport Assays
Membrane Vesicles—Glutamate uptake in rightside-out membrane
vesicles was measured by rapid filtration. Membrane vesicles were
either energized using the potassium ascorbate/phenazine methosul-
fate electron donor system or by artificial gradients. In the former case,
the membranes were diluted to a concentration of 0.6 mg/ml in 50 mM
potassium phosphate, pH 7, and 10 mM potassium ascorbate. The
uptake experiments were performed in 100 ml at 30 °C under a constant
flow of water-saturated air. Phenazine methosulfate was added at a
concentration of 100 mM, and the proton motive force was allowed to
develop for 2 min, after which L-[14C]glutamate (Amersham Pharmacia
Biotech) was added to a final concentration of 1.9 mM. The uptake was
stopped by adding a 20-fold excess of ice-cold 0.1 M LiCl solution,
followed by immediate filtration over cellulose nitrate filters (pore size,
0.45 mm). The filters were washed once with 2 ml of 0.1 M LiCl and
assayed for radioactivity. When artificial gradients were used, a buffer
system described previously was used (20). Membrane vesicles (10 mg
protein/ml) were loaded with a buffer containing 25 mM potassium
phosphate, pH 7, 100 mM potassium acetate, pH 7, and 1 mM valinomy-
cin. Proton motive force-driven uptake was initiated by diluting the 4-ml
vesicles into 330 ml of buffer containing 125 mM MES, adjusted to pH 6
with methylglucamine, 1 mM valinomycin, and 0.6 mM L-[14C]glutamate
and incubated at 30 °C. The uptake was stopped as described above.
Proteoliposomes—For counterflow experiments proteoliposomes
were loaded with 25 mM potassium phosphate and 5 mM potassium
glutamate, pH 7, by freeze thawing followed by extrusion through
polycarbonate filters (pore size, 400 nm). Proteoliposomes were concen-
trated by centrifugation (250,000 3 g, 20 min, 10 °C) and resuspended
1 The abbreviations used are: NEM, N-ethylmaleimide; MTSET, (2-
(trimethylammonium)ethyl) methanethiosulfonate bromide; MTSEA,
2-aminoethyl methanethiosulfonate hydrobromide; AMdiS, 4-acet-
amido-49-maleimidylstilbene-2,29-disulfonic acid; MES, 2-(N-morpholi-
no)ethanesulfonic acid..
FIG. 1. Model for the membrane topology of glutamate trans-
porters. Numbered rectangles indicate membrane-spanning segments.
The reentrant loops are numbered 6a and 7a.
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at a protein concentration of ;0.2 mg/ml. Counterflow was initiated by
diluting 4 ml of proteoliposomes into 330 ml of 30 mM potassium phos-
phate, pH 7, prewarmed at 30 °C, and containing 1.2 mM L-[14C]gluta-
mate. The uptake was stopped as described above. Glutamate uptake
driven by artificial gradients in proteoliposomes was assayed using the
same procedure as described for counterflow but with the buffer system
for artificial gradient described above.
To measure efflux, proteoliposomes were loaded with L-[14C]gluta-
mate using the artificial gradient method until ;10 pmol/mg of protein
was taken up by the proteoliposomes. 10 mM Carbonyl cyanide p-triflu-
oromethoxyphenylhydrazone was added, and the efflux reaction was
stopped at several time points by diluting aliquots of the reaction
mixture in ice-cold 0.1 M LiCl followed by rapid filtration as described
above.
RESULTS
Construction, Expression, and Activity of Single Cysteine Mu-
tants—The cysteineless version of GltT, which was shown pre-
viously to have glutamate uptake activity similar to that of the
wild type (9), was used as background for the construction of a
set of 21 single cysteine mutants in the region of membrane-
spanning segment 8 (Fig. 1). Each residue in the amino acid
stretch that is highly amphipathic when modeled an a-helix
(residues 374–392) (5) was mutated to cysteine, as well as
selected residues at the carboxyl-terminal end of the stretch.
Out of the 21 mutants 19 could be expressed in E. coli and were
present in the cytoplasmic membrane as judged from Western
blots using antibodies raised against the amino-terminal His
tag which is present in all mutants (Fig. 2A). Only two mu-
tants, D376C and G390C, were not found in the membrane of
E. coli (not shown). The glutamate transport activity of the
mutants that were expressed was measured in membrane ves-
icles with a rightside-out orientation. At most of the positions
cysteine mutations were well tolerated by the transporter re-
sulting in glutamate transport activities between 40 and 125%
of the cysteineless mutant (Fig. 2B). In four mutants (D380C,
R383C, T384C, and N387C) glutamate transport was com-
pletely abolished. In two other mutants, R377C and M381C,
glutamate uptake was measurable but severely impaired (5
and 17% of the activity of the cysteineless mutant, respectively)
(Fig. 2B). In none of these mutants was the impaired or abol-
ished activity caused by a reduced level of expression (Fig. 2A).
Labeling of Single Cysteine Mutants with Fluorescein Male-
imide—The accessibility of the cysteine residues in the GltT
mutants for the large maleimide compound fluorescein male-
imide (molecular weight 427) was determined. Randomly ori-
ented membrane vesicles were prepared from cells expressing
the various GltT mutants and labeled with fluorescein male-
imide. Subsequently, the vesicles were solubilized, and His-
tagged GltT mutants were purified, followed by SDS-polyacryl-
amide gel electrophoresis. Fluorescence of GltT mutants
labeled with fluorescein maleimide was detected by UV
excitation.
The cysteineless mutant was used as a negative control and
was not modified by fluorescein maleimide (not shown). Only
four single cysteine mutants (G374C, I375C, S399C, and
Q404C) were labeled with fluorescein maleimide (Fig. 3). The
cysteine residues in the four mutants are located at the ex-
treme amino and carboxyl termini of the mutated stretch. The
accessibility of these residues for fluorescein maleimide indi-
cates a location in the protein structure, which is well exposed
to the aqueous environment and is consistent with a position in
a loop structure. The other single cysteine mutants could not be
labeled with fluorescein maleimide, as exemplified by mutants
R377C, A382C, and S392C (Fig. 3). The cysteine residues in
these mutants are either buried in the protein structure or
exposed to the lipid environment.
Although mutants G374C, I375C, and S399C were readily
labeled with fluorescein maleimide, the accessibility of the
cysteine residues in these mutants is not completely unre-
stricted: biotin maleimide (molecular weight 524), which was
used previously in membrane topology studies of GltT (9), did
not label these mutants (not shown). Only the single cysteine in
mutant Q404C was readily labeled with biotin maleimide in
membrane vesicles with an inside-out orientation, and labeling
was prevented by preincubation with the charged maleimide
AMdiS, suggesting a cytoplasmic location (9). In agreement,
Q404C was not labeled with biotin maleimide in whole cells
(not shown).
Effect of NEM, MTSEA, and MTSET on Transport Activity—
The effect of cysteine modification on glutamate transport ac-
tivity was determined in membrane vesicles with a rightside-
out orientation prepared from E. coli cells expressing the single
cysteine mutants. Three small modifying reagents were used:
FIG. 2. Activity and expression of single cysteine GltT mu-
tants. Panel A, expression levels of the mutants on Western blots
stained with antibodies raised against the His tag. Mutant R377C is not
shown, but see Figs. 3B and 7A. Panel B, initial rates of glutamate
uptake in rightside-out membrane vesicles containing the single cys-
teine mutants were expressed as a percentage of the rate in membrane
vesicles containing the cysteineless mutant.
FIG. 3. Fluorescein maleimide labeling of single cysteine mu-
tants. Membrane vesicles from cells expressing single cysteine mutants
were labeled with fluorescein maleimide, and His-tagged proteins were
purified and run on SDS-polyacrylamide gels. Panel A, fluorescence of
fluorescein maleimide-labeled proteins in the gel using UV excitation.
Panel B, the same gel was stained with Coomassie Brilliant Blue to
compare the amounts of protein.
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NEM and MTSEA, which are membrane-permeable, and
MTSET, which is charged and reportedly membrane-imperme-
able (26, 27). Treatment with NEM did not affect glutamate
uptake of the cysteineless mutant when the vesicles were en-
ergized with the artificial electron donor system ascorbate/
phenazine methosulfate (9). In contrast, the methanethiosul-
fonate reagents severely reduced glutamate uptake activity by
the cysteineless mutant using the same energizing method.
Apparently, the reagents interfere with the generation of a
proton motive force by inhibition of one of the components of
the electron transport chain. Therefore, the proton motive force
was generated using a combination of acetic acid and K1 dif-
fusion gradients (20). Glutamate transport catalyzed by the
cysteineless mutant driven by the diffusion gradients was not
significantly affected by the methanethiosulfonate reagents or
NEM (Fig. 4A).
One of the four mutants that were labeled with fluorescein
maleimide (Fig. 3), G374C, was inactivated by both the mem-
brane-permeable and membrane-impermeable modifying re-
agents, consistent with accessibility from the outside (Fig. 4A).
In contrast, mutant S399C was inactivated by the membrane-
permeable reagents MTSEA and NEM but not by the mem-
brane-impermeable MTSET. This behavior is consistent with a
cytoplasmic accessibility. The other mutants that were labeled
with fluorescein maleimide, I375C and Q404C, were not inac-
tivated by NEM (Fig. 4A). Similarly the MTS reagents did not
inactivate mutant Q404C, whereas the activity of mutant
I375C was only slightly affected by the reagents. Apparently,
modification of the single cysteines in these mutants is well
tolerated.
In the set of single cysteine mutants that were not labeled
with fluorescein maleimide, three mutants, M381C, V388C,
and N391C, could be inactivated by the membrane-permeable
reagent MTSEA but not by the membrane-impermeable rea-
gent MTSET and also not by NEM (Fig. 4A). Apparently, ac-
cessibility of the cysteine residues is very much restricted,
allowing the small and flexible MTSEA reagent, but not NEM,
which has a more constrained structure, to reach the residues.
Because the membrane-impermeable analogue MTSET did not
inhibit the three mutants, the cysteines in the mutants appear
to be accessible through a narrow aqueous pore from the cyto-
plasmic side of the membrane.
Finally, the activity of most of the mutants that were not
labeled with fluorescein maleimide was not affected by any of
the modifying reagents. These mutants either tolerated modi-
fication or could not be modified at all because they were not
accessible. Based on the results described here it is not possible
to distinguish between the two possibilities. When the region
between Gly-374 and Ser-392 is modeled as an a-helix, all
inactive, severely impaired, and nonexpressed mutants cluster
on one face of the helix (black circles in Fig. 5B), whereas the
active mutants cluster on the other face (bars in Fig. 5A and
open circles in 5B). The mutants that were inactivated by the
cysteine-modifying reagents also cluster on one face of the
helix. This face partially overlaps with the face of the helix
containing the inactive mutants (gray bars and gray circles in
Fig. 5, A and B, respectively).
Kinetics of MTSET Labeling—Mutant G374C that is acces-
sible from the periplasmic side of the membrane was inacti-
vated with the membrane-impermeable reagent MTSET with a
half-time of 1–2 min (Fig. 4B). Mutant S399C that is located at
the cytoplasmic side of the membrane was not significantly
inactivated in 10 min. However, longer incubations did result
in partial inactivation of the mutant. This is most likely caused
by a slow permeability of the reagent followed by access from
the cytoplasmic side of the membrane. Similar observations
were made for mutants M381C, V388C, and N391C (shown for
V388C and N391C in Fig. 4B), suggesting a similar accessibil-
ity from the cytoplasmic side of the membrane following the
slow permeation of the reagent.
Orientation of GltT in Proteoliposomes—A more detailed ki-
netic characterization of the single cysteine mutants was done
in proteoliposomes. A procedure to purify GltT and to reconsti-
tute the protein into proteoliposomes was described before (25).
To interpret correctly results obtained with single cysteine
mutants reconstituted in proteoliposomes (below), the orienta-
tion of GltT in the liposomal membrane was determined. Two
single cysteine mutants, S129C and S292C, which were char-
acterized before and which contain cysteines with well defined
extra- and intracellular locations, respectively (9), were puri-
fied and reconstituted into proteoliposomes. The membrane-
impermeable maleimide AMdiS was used to label cysteines
that are accessible from the outside of the proteoliposomes,
whereas NEM was used to label cysteines on both sides of the
membrane. Subsequently, unreacted cysteines were labeled
with fluorescein maleimide, and the extent of fluorescein label-
ing was measured. In proteoliposomes, mutant S129C, which
has an extracellular cysteine, was fully accessible for both
AMdiS and NEM, indicating that the orientation of the protein
in the proteoliposomes is rightside-out (Fig. 6). Consistent with
FIG. 4. Effect of treatment of GltT
single cysteine mutants with cys-
teine-modifying reagents. Panel A, ini-
tial rates of glutamate uptake in right-
side-out membrane vesicles after
treatment with NEM (black bars), MT-
SEA (gray bars), and MTSET (white
bars). Rates were expressed as percent-
age of the initial rates in untreated mem-
brane vesicles. Panel B, kinetics of inacti-
vation of GltT mutants with MTSET.
Membrane vesicles with a rightside-out
orientation expressing mutants G374C
(l), V388C (u), and N391C (t) were
treated with MTSET for the indicated
time periods, immediately followed by
glutamate uptake assays. Initial rates of
proton motive force-driven glutamate up-
take were expressed as a percentage of
the rates in untreated membrane vesi-
cles. G374C, closed circles; V388C, open
squares; and N391C, closed triangles.
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this result, the single cysteine in mutant S292C, which has an
intracellular location, was accessible for NEM but not for the
membrane-impermeable AMdiS. The rightside-out orientation
of GltT in proteoliposomes allows a fair comparison of the
studies with membrane vesicles and proteoliposomes.
Glutamate Transport Activity in Proteoliposomes—Trans-
porter mutants that do not show activity when transport is
driven by the proton motive force may show activity when
assayed for a partial transport reaction like exchange (see, e.g.
Refs. 13 and 28). In such cases the mutant transporter may be
unable to complete the catalytic cycle because the reorientation
of the unloaded carrier is impaired, a step that is omitted in the
exchange mode, whereas the reorientation of the substrate-
loaded carrier is unaffected. The exchange reaction catalyzed
by GltT was measured using a previously described counter-
flow assay in proteoliposomes (25). Mutants R377C, D380C,
R383C, T384C, and N387C, which were inactive or showed
severely impaired glutamate transport activity (Fig. 2), as well
as the cysteineless mutant and mutants G374C and N391C,
were successfully purified and reconstituted into proteolipo-
somes using the protocol developed for the wild-type protein
(Fig. 7A). Proton motive force-driven glutamate uptake of the
mutant proteins in proteoliposomes was comparable with the
activity in membrane vesicles (Fig. 7B, solid bars). G374C and
N391C showed approximately 50% of the activity of the cys-
teineless mutant, transport by R377C was severely impaired,
but measurable and the other transporters were inactive.
When counterflow was measured the results did not differ
FIG. 5. a-Helical model of the stretch between Gly-374 and
Ser-392. Panel A, helical wheel representation of the amino acid se-
quence between Gly-374 and Ser-392 modeled as an a-helix. The bars
represent the activities of the single cysteine mutants at each position.
Shaded bars indicate activities that were blocked by cysteine-modifying
reagents (Fig. 4A). Asterisks indicate mutants that were not expressed.
The arrows pointing to the right and left represent the hydrophobic and
substitution moments, respectively, as calculated previously (16). Panel
B, side view of the a-helical model of the region between Gly-374 and
Ser-392. Solid and dashed lines connect residues on the front and the
back of the helix, respectively. The positions of the cysteine residues in
mutants that are susceptible for inactivation by cysteine-modifying
reagents and the residues of which cysteine mutation results in inactive
or nonexpressed mutants are shown in gray and black, respectively.
FIG. 6. Orientation of GltT in proteoliposomes. Proteoliposomes
containing mutants S129C (panel A) and S292C (panel B) were treated
with NEM, AMdiS, or buffer (no addition). Unmodified cysteines were
labeled with fluorescein maleimide, and the proteins were run on SDS-
polyacrylamide gels. Fluorescence of fluorescein maleimide-labeled pro-
teins in the gel was measured using UV excitation.
FIG. 7. Activity of GltT mutants in proteoliposomes. Panel A,
Coomassie Brilliant Blue-stained SDS-polyacrylamide gels of GltT mu-
tants purified on Ni21-NTA agarose columns. Panel B, initial rates of
proton motive force- and counterflow-driven glutamate uptake in pro-
teoliposomes (black and white bars, respectively). Rates are expressed
as percentage of the initial rate of glutamate uptake in proteoliposomes
containing the cysteineless mutant. Panel C, efflux of radiolabeled
glutamate from proteoliposomes containing the cysteineless mutant (V
or mutant N391C (l ).
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significantly from proton motive force-driven transport for
most mutants (Fig. 7B, open bars), indicating that mutants
R377C, D380C, R383C, T384C, and N387C are not only im-
paired in the complete reaction cycle but also in the partial
exchange reaction. Surprisingly, counterflow by mutant N391C
was severely reduced compared with proton motive force-
driven transport. Because efflux catalyzed by mutant N391C is
also severely reduced (Fig. 7C), the impaired counterflow ac-
tivity of the mutant was not caused an inability to maintain the
necessary gradient of glutamate across the membrane. There-
fore, the reduced counterflow activity of mutant N291C may be
the result of a reduced affinity for cytoplasmic glutamate, an
impaired reorientation of the substrate loaded carrier, or a
stringent dependence on the presence of the proton motive
force even in the exchange mode.
Glutamate Binding—A qualitative method was developed to
measure glutamate binding in GltT mutants R377C, D380C,
R383C, T384C, and N387C, which were inactive or severely
impaired in proton motive force-driven glutamate uptake. The
previously described single cysteine mutant S269C in the re-
entrant loop between membrane-spanning helix 6 and 7 (Fig. 1)
could be labeled with biotin maleimide in whole cells, and
labeling was prevented by the presence of L-glutamate (Fig. 8)
(9). In contrast, none of the inactive mutants described here
(R377C, D380C, R383C, T384C, and N387C) could be labeled
with biotin maleimide, either in whole cells or in membrane
vesicles (not shown). Double mutants were constructed in
which mutation S269C was combined with each of the five
mutations that impaired glutamate transport. The double mu-
tants were expressed in E. coli and could be labeled in whole
cells with biotin maleimide, just like the single mutant S269C
(Fig. 8). In the double mutants the cysteine at position 269
serves as indicator for glutamate binding. Labeling of the cys-
teine in double mutant R377C/S269C could be prevented by the
presence of glutamate, indicating normal glutamate binding,
even though mutant R377C displayed strongly reduced gluta-
mate transport activity (Figs. 2 and 7). 5 mM L-glutamate did
not prevent the labeling with biotin maleimide of the double
mutants D380C/S269C, R383C/S269C, T384C/S269C, and
N387C/S269C, indicating that in these mutants glutamate
binding is completely abolished.
DISCUSSION
Cysteine-scanning mutagenesis has been used to study the
membrane topology of several members of the family of gluta-
mate transporters (7–11). The proteins have a highly unusual
structure, consisting of eight membrane-spanning segments
and two reentrant loops (Fig. 1). There is still some controversy
about the exact membrane topology of part of the proteins and,
in particular, on the exact position and secondary structure of
the most carboxyl-terminal, inward-going, membrane-span-
ning segment (segment 8). In this report, membrane-spanning
segment 8 was studied by cysteine-scanning mutagenesis in
the glutamate transporter GltT of the bacterium B. stearother-
mophilus. 21 single cysteine mutants were constructed in a
stretch of 30 residues from Gly-374 to E-404, and the mem-
brane-spanning segment could be confined to this stretch by
the following criteria.
One mutant (G374C) reacted with both charged and un-
charged cysteine-modifying reagents in membrane vesicles
with a rightside-out orientation, consistent with a location in
an aqueous environment at the extracellular side of the mem-
brane. Furthermore, the bulky molecule fluorescein maleimide
labeled the cysteine as well as the cysteine at the adjacent
position in mutant I375C, indicative of a spacious access route
and a location in a loop structure outside of the membrane. The
result is consistent with cysteine-scanning mutagenesis stud-
ies in the human glutamate transporter EAAT1, where a cys-
teine at the corresponding position (A470C) was modeled at the
extracellular side of the membrane (11).
In contrast, mutant S399C, the more carboxyl-terminal mu-
tant Q404C, and the previously described mutant Q412C had
labeling characteristics of residues located in a loop structure
in the aqueous environment at the cytoplasmic side of the
membrane. The cysteines in these mutants were accessible for
the bulky molecule fluorescein maleimide. Furthermore, mu-
tant S399C was labeled with membrane permeable cysteine-
modifying reagents only in membrane vesicles with a rightside-
out orientation. Cysteines at positions between Ile-375 and
Ser-399 were not labeled with fluorescein maleimide. There-
fore, the location of the eighth membrane-spanning segment
seems to be confined to a stretch of 23 residues between Ile-375
and Ser-399, which is significantly shorter compared with pre-
vious studies that showed at least 50 residues between residues
at the extra- and intracellular side of the membrane (10, 11).
The secondary structure of membrane-spanning segment 8
has been a matter of debate, and it has been modeled as both as
an a-helix and a b-strand (10, 11, 16, 19). Because a hydropho-
bic stretch of approximately 20 residues, which is indicative of
a membrane-spanning a-helix, is not found at the position of
segment 8, the presence of a membrane-spanning b-strand was
suggested (11, 19). On the other hand, the stretch of amino acid
residues that we experimentally showed to be membrane-span-
ning has been modeled as an a-helix before, based on compu-
tational analysis of the periodicity in the amino acid sequences
of glutamate transporters (5, 16). When modeled as an a-helix
the region between Gly-374 and Ser-392 is highly amphipathic
(Fig. 5A) with all well conserved charged and polar residues
clustering on one face of the helix and all hydrophobic residues,
which are not conserved, clustering on the opposite face (16).
Periodicity consistent with an a-helical conformation is also
observed in the properties of the cysteine mutants described
here. All positions at which cysteine mutations are tolerated
cluster on the hydrophobic, nonconserved face of the helix,
whereas residues that cannot be mutated to cysteine without
loss of activity cluster on the opposite face of the helix (Fig. 5,
A and B). Furthermore, cysteine mutants that can be inacti-
vated by cysteine-modifying reagents also cluster on the same
face of the helix. The results strongly suggest that membrane-
spanning segment 8 is a-helical. An a-helical conformation of
the segment would solve the problem of accommodating the
charged and polar residues in the hydrophobic core of the
membrane. If the hydrophilic face of the helix were buried
FIG. 8. Protection by L-glutamate against labeling of Cys-269
with biotin maleimide in double mutants of GltT. Western blots
are shown of purified mutant S269C and double mutants S269C/R377C,
S269C/D380C, S269C/R383C, S269C/T384C, and S269C/N287C labeled
with biotin maleimide in whole cells in the presence (1) or absence (2)
of 5 mM L-glutamate. Western blots were decorated with streptavidin
coupled to alkaline phosphatase to detect biotinylated proteins.
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within the protein core it would be effectively shielded from the
hydrophobic lipid bilayer by the hydrophobic face.
Interestingly, cysteine residues in three mutants (M381C,
V388C, and N391C), which are distributed along the long axis
of membrane-spanning helix 8 at the hydrophilic face, were
accessible for the cysteine-modifying reagent MTSEA (Fig. 4).
This indicates that there must be an aqueous path through the
protein which provides an access route to the residues. The
water-filled pore is not very spacious because only small and
flexible cysteine-modifying reagents can enter it. The narrow
aqueous path along membrane-spanning helix 8 contrasts with
the very spacious water-filled pore, which was found around
the reentrant loop between helices 6 and 79. Therefore, it is
unlikely that the two water-accessible pores are parts of one
single larger pore. Cysteine-scanning mutagenesis in two re-
lated glutamate transporters, human EAAT1 and rat EAAT2,
showed that helix 7 also contains water-accessible residues of
which the accessibility is restricted to small reagents (7, 11,
12). The similar accessibility behavior of helices 7 and 8 sug-
gests that the two helices may be close together in space.
Since the first mutagenesis experiments of glutamate trans-
porters it is known that certain residues in membrane-span-
ning helix 8 are of crucial importance for function (11, 28–30).
Particularly well characterized is the arginine residue at the
corresponding position of Arg-383 in GltT, which is conserved
in all glutamate transporters of the family (5). Mutations at
this position in the human glutamate transporters EAAT1 and
EAAT3 as well as the glutamate transporters EAAT1 and
EAAT2 from rat completely abolished glutamate transport (11,
28–30). Interestingly, the arginine mutant in EAAT3 (R447C)
was still able to transport cysteine, which is a substrate of
EAAT3 but not of the other glutamate transporters. It was
concluded that Arg-447 is involved in the binding of the g-car-
boxylate group of glutamate (28). The observation that mutant
R383C in GltT was completely inactive and could not bind
glutamate is consistent with the findings in EAAT3.
In addition, the results presented here show that many other
residues at the hydrophilic face of membrane-spanning helix 8
at positions ranging from the extracellular to the cytoplasmic
side of the membrane are of crucial importance for the trans-
porter’s function. Starting at the amino-terminal end of the
helix, mutant R377C was severely impaired in glutamate
transport but could still bind glutamate. Subsequently, three
mutants, D380C, T384C, and N387C, behaved similarly to
mutant R383C: These mutants do not transport glutamate in
either the proton motive force-driven uptake mode or the
exchange mode and do not bind glutamate. Finally, three mu-
tants, M381C, V388C, and N391C, with cysteines at the hydro-
philic face of the helix, could be inactivated by cysteine-modi-
fying reagents. In the latter mutant glutamate exchange and
efflux activities were severely impaired, whereas proton motive
force-driven glutamate uptake was only mildly affected. Possi-
bly, Asn-391 is involved in binding of cytoplasmic glutamate,
which would be consistent with its location at the cytoplasmic
end of membrane-spanning segment 8.
In addition to membrane-spanning segment 8 several other
regions in the glutamate transporters are important for bind-
ing of glutamate, binding of cotransported cations, and trans-
location. These regions include the reentrant loop between
helices 6 and 78, 9, helix 77, 13, 15, and the reentrant loop
between helices 7 and 814. Further work is required to find the
spatial relation between these regions. In such studies the
multimeric structure of the transporters will also have to be
considered. Recently, it was reported that the human gluta-
mate transporter EAAT3 is present as a pentamer in oocyte
membranes (31). It is not known whether a pentameric struc-
ture is common among glutamate transporters and, impor-
tantly, whether the monomer subunits functionally interact.
Such information will be required to build a model for the
substrate binding site and the translocation path.
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